{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:02:54Z","timestamp":1779332574611,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Serratia marcescens,<\/jats:italic> a Gram-negative nosocomial pathogen secretes a 50\u00a0kDa multi-domain zinc metalloprotease called serratiopeptidase. Broad substrate specificity of serratiopeptidase makes it suitable for detergent and food processing industries The protein shows potent anti-inflammatory, anti-edemic, analgesic, antibiofilm activity and sold as an individual or fixed-dose enteric-coated tablets combined with other drugs. Although controversial, serratiopeptidase as drug is used in the treatment of chronic sinusitis, carpal tunnel syndrome, sprains, torn ligaments, and postoperative inflammation. Since the native producer of serratiopeptidase is a pathogenic microorganism, the current production methods need to be replaced by alternative approaches. Heterologous expression of serratiopeptidase in <jats:italic>E. coli<\/jats:italic> was tried before but not found suitable due to the limited yield, and other expression related issues due to its inherent proteolytic activity such as cytotoxicity, cell death, no expression, minimal expression, or inactive protein accumulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Recombinant expression of mature form serratiopeptidase in <jats:italic>E. coli<\/jats:italic> seems toxic and resulted in the failure of transformation and other expression related issues. Although <jats:italic>E. coli C43(DE3)<\/jats:italic> cells, express protein correctly, the yield was compromised severely. Optimization of protein expression process parameters such as nutrient composition, induction point, inducer concentration, post-induction duration, etc., caused significant enhancement in serratiopeptidase production (57.9\u2009\u00b1\u20090.73% of total cellular protein). Expressed protein formed insoluble, enzymatically inactive inclusion bodies, and gave 40\u201345\u00a0mg\/l homogenous (&gt;\u200998% purity) biologically active and conformationally similar serratiopeptidase to the commercial counterpart upon refolding and purification.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Expression of mature serratiopeptidase in <jats:italic>E. coli C43(DE3)<\/jats:italic> cells eliminated the protein expression associated with toxicity issues. Further optimization of process parameters significantly enhanced the overexpression of protein resulting in the higher yield of pure and functionally active recombinant serratiopeptidase. The biological activity and conformational features of recombinant serratiopeptidase were very similar to the commercially available counterpart suggesting it-a potential biosimilar of therapeutic and industrial relevance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12934-019-1267-x","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T18:02:58Z","timestamp":1576605778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Enhanced production of recombinant serratiopeptidase in Escherichia coli and its characterization as a potential biosimilar to native biotherapeutic counterpart"],"prefix":"10.1186","volume":"18","author":[{"given":"Vishal","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivam","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapan K.","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"issue":"1","key":"1267_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/nar\/30.1.343","volume":"30","author":"ND Rawlings","year":"2002","unstructured":"Rawlings ND, O\u2019Brien E, Barrett AJ. MEROPS: the protease database. Nucleic Acids Res. 2002;30(1):343\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1267_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1074\/mcp.M500004-MCP200","volume":"4","author":"DN Gosalia","year":"2005","unstructured":"Gosalia DN, Salisbury CM, Ellman JA, Diamond SL. High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays. Mol Cell Proteomics. 2005;4(5):626\u201336.","journal-title":"Mol Cell Proteomics"},{"key":"1267_CR3","doi-asserted-by":"crossref","unstructured":"Kalisz HM. Microbial proteinases. In: Enzyme studies. Berlin: Springer; 1988. p. 1\u201365.","DOI":"10.1007\/BFb0047944"},{"issue":"2","key":"1267_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/1541-4337.12326","volume":"17","author":"OL Tavano","year":"2018","unstructured":"Tavano OL, Berenguer-Murcia A, Secundo F, Fernandez-Lafuente R. Biotechnological applications of proteases in food technology. Compr Rev Food Sci Food Saf. 2018;17(2):412\u201336.","journal-title":"Compr Rev Food Sci Food Saf"},{"issue":"6","key":"1267_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s40974-017-0076-5","volume":"2","author":"S Singh","year":"2017","unstructured":"Singh S, Bajaj BK. Potential application spectrum of microbial proteases for clean and green industrial production. Energy Ecol Environ. 2017;2(6):370\u201386.","journal-title":"Energy Ecol Environ"},{"issue":"1","key":"1267_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.17113\/ftb.56.01.18.5491","volume":"56","author":"S Raveendran","year":"2018","unstructured":"Raveendran S, Parameswaran B, Ummalyma SB, Abraham A, Mathew AK, Madhavan A, et al. Applications of microbial enzymes in food industry. Food Technol Biotechnol. 2018;56(1):16\u201330.","journal-title":"Food Technol Biotechnol."},{"issue":"2","key":"1267_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/cpt196012202","volume":"1","author":"S Sherry","year":"1960","unstructured":"Sherry S, Fletcher AP. Proteolytic enzymes: a therapeutic evaluation. Clin Pharmacol Ther. 1960;1(2):202\u201326.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"1267_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0305-4179(99)00117-5","volume":"26","author":"HJ Klasen","year":"2000","unstructured":"Klasen HJ. A review on the nonoperative removal of necrotic tissue from burn wounds. Burns. 2000;26(3):207\u201322.","journal-title":"Burns."},{"issue":"3","key":"1267_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/01.WON.0000319125.21854.78","volume":"35","author":"J Ramundo","year":"2008","unstructured":"Ramundo J, Gray M. Enzymatic wound debridement. J Wound Ostomy Cont Nurs. 2008;35(3):273\u201380.","journal-title":"J Wound Ostomy Cont Nurs."},{"issue":"5","key":"1267_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/01.moh.0000239712.93662.35","volume":"13","author":"CT Esmon","year":"2006","unstructured":"Esmon CT. The endothelial protein C receptor. Curr Opin Hematol. 2006;13(5):382\u20135.","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"1267_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20100965","volume":"435","author":"CS Craik","year":"2011","unstructured":"Craik CS, Page MJ, Madison EL. Proteases as therapeutics. Biochem J. 2011;435(1):1\u201316.","journal-title":"Biochem J"},{"issue":"4","key":"1267_CR12","first-page":"95","volume":"3","author":"CS Anil","year":"2013","unstructured":"Anil CS, Kashinath MA. Production, characterization & optimization of potent protease (serratiopeptidase) from Serratia marcescens e 15. Int Res J Pharm Appl Sci. 2013;3(4):95\u20138.","journal-title":"Int Res J Pharm Appl Sci."},{"key":"1267_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/0-387-30746-X_9","volume":"6","author":"F Grimont","year":"2006","unstructured":"Grimont F, Grimont PAD. The genus Serratia. Prokaryotes. 2006;6:197\u2013214.","journal-title":"Prokaryotes."},{"issue":"3","key":"1267_CR14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/IAI.53.3.522-529.1986","volume":"53","author":"A Molla","year":"1986","unstructured":"Molla A, Matsumoto K, Oyamada I, Katsuki T, Maeda H. Degradation of protease inhibitors, immunoglobulins, and other serum protein by Serratia protease and its toxicity to fibroblasts in culture. Infect Immun. 1986;53(3):522\u20139.","journal-title":"Infect Immun"},{"issue":"1","key":"1267_CR15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JB.157.1.225-232.1984","volume":"157","author":"K Matsumoto","year":"1984","unstructured":"Matsumoto K, Maeda H, Takata K, Kamata R, Okamura R. Purification and characterization of four proteases from a clinical isolate of Serratia marcescens kums 3958. J Bacteriol. 1984;157(1):225\u201332.","journal-title":"J Bacteriol"},{"issue":"5","key":"1267_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/oxfordjournals.jbchem.a021320","volume":"119","author":"K Hamada","year":"1996","unstructured":"Hamada K, Hata Y, Katsuya Y, Hiramatsu H, Fujiwara T, Katsube Y. Crystal structure of Serratia protease, a zinc-dependent proteinase from Serratia sp. E-15, containing a \u03b2-sheet coil motif at 2.0\u00a0\u212b resolution. J Biochem. 1996;119(5):844\u201351.","journal-title":"J Biochem."},{"issue":"4","key":"1267_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1128\/CMR.00017-11","volume":"24","author":"SD Mahlen","year":"2011","unstructured":"Mahlen SD. Serratia infections: from military experiments to current practice. Clin Microbiol Rev. 2011;24(4):755\u201391.","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"1267_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1139\/cjm-2013-0343","volume":"59","author":"LM Petersen","year":"2013","unstructured":"Petersen LM, Tisa LS. Friend or foe? A review of the mechanisms that drive Serratia towards diverse lifestyles. Can J Microbiol. 2013;59(9):627\u201340.","journal-title":"Can J Microbiol"},{"issue":"7","key":"1267_CR19","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/emboj\/cdg159","volume":"22","author":"C Kurz","year":"2003","unstructured":"Kurz C, Chauvet S, Andr\u00e8s E, Aurouze M, Vallet I, Michel GP, Uh M, Celli J, Filloux A, de Bentzmann S, Steinmetz I, Hoffmann JA, Finlay B, Gorvel J, Ferrandon D, Ewbank JJ. Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J. 2003;22(7):1451\u201360.","journal-title":"EMBO J"},{"issue":"1","key":"1267_CR20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/IAI.40.1.113-119.1983","volume":"40","author":"DM Lyerly","year":"1983","unstructured":"Lyerly DM, Kreger AS. Importance of serratia protease in the pathogenesis of experimental Serratia marcescens pneumonia. Infect Immun. 1983;40(1):113\u20139.","journal-title":"Infect Immun"},{"issue":"1","key":"1267_CR21","first-page":"932","volume":"40","author":"AS Kreger","year":"1986","unstructured":"Kreger AS, Lyerly DM, Hazlett LD, Berk RS. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Infect Immun. 1986;40(1):932\u20139.","journal-title":"Infect Immun"},{"issue":"5","key":"1267_CR22","doi-asserted-by":"publisher","first-page":"950","DOI":"10.4014\/jmb.0911.11023","volume":"20","author":"RC Pansuriya","year":"2010","unstructured":"Pansuriya RC, Singhal RS. Evolutionary operation (EVOP) to optimize whey-independent serratiopeptidase production from Serratia marcescens NRRL B-23112. J Microbiol Biotechnol. 2010;20(5):950\u20137.","journal-title":"J Microbiol Biotechnol"},{"issue":"3","key":"1267_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-017-0808-4","volume":"7","author":"K Taneja","year":"2017","unstructured":"Taneja K, Bajaj BK, Kumar S, Dilbaghi N. Production, purification and characterization of fibrinolytic enzyme from Serratia sp. KG-2-1 using optimized media. 3 Biotech. 2017;7(3):1\u201315.","journal-title":"3 Biotech."},{"issue":"3","key":"1267_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijsu.2013.01.010","volume":"11","author":"S Bhagat","year":"2013","unstructured":"Bhagat S, Agarwal M, Roy V. Serratiopeptidase: a systematic review of the existing evidence. Int J Surg. 2013;11(3):209\u201317.","journal-title":"Int J Surg"},{"issue":"5","key":"1267_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/030006059001800506","volume":"18","author":"A Mazzone","year":"1990","unstructured":"Mazzone A, Catalani M, Costanzo M, Drusian A, Mandoli A, Russo S, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind randomized trial versus placebo. J Int Med Res. 1990;18(5):379\u201388.","journal-title":"J Int Med Res"},{"issue":"1","key":"1267_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00044011-200019010-00003","volume":"19","author":"G Klein","year":"2000","unstructured":"Klein G, Kullich W. Short-term treatment of painful osteoarthritis of the knee with oral enzymes. A randomised, double-blind study versus diclofenac. Clin Drug Investig. 2000;19(1):15\u201323.","journal-title":"Clin Drug Investig."},{"key":"1267_CR27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.msec.2016.09.049","volume":"70","author":"SK Metkar","year":"2017","unstructured":"Metkar SK, Girigoswami A, Murugesan R, Girigoswami K. In vitro and in vivo insulin amyloid degradation mediated by serratiopeptidase. Mater Sci Eng C. 2017;70:728\u201335.","journal-title":"Mater Sci Eng C"},{"issue":"1","key":"1267_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12866-015-0548-8","volume":"15","author":"L Selan","year":"2015","unstructured":"Selan L, Papa R, Tilotta M, Vrenna G, Carpentieri A, Amoresano A, et al. Serratiopeptidase: a well-known metalloprotease with a new non-proteolytic activity against S. aureus biofilm. BMC Microbiol. 2015;15(1):207.","journal-title":"BMC Microbiol."},{"issue":"2","key":"1267_CR29","first-page":"243","volume":"7","author":"A Khanna","year":"2013","unstructured":"Khanna A, Khanna M, Aggarwal A. Serratia marcescens\u2014a rare opportunistic nosocomial pathogen and measures to limit its spread in hospitalized patients. J Clin Diagn Res. 2013;7(2):243\u20136.","journal-title":"J Clin Diagn Res."},{"issue":"12","key":"1267_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1099\/00222615-47-12-1105","volume":"47","author":"HM Aucken","year":"1998","unstructured":"Aucken HM, Pitt TL. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes. J Med Microbiol. 1998;47(12):1105\u201313.","journal-title":"J Med Microbiol"},{"issue":"8","key":"1267_CR31","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1086\/501795","volume":"21","author":"MJ Richards","year":"2010","unstructured":"Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2010;21(8):510\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"81","key":"1267_CR32","first-page":"1","volume":"5","author":"Petra Gastmeier","year":"2014","unstructured":"Gastmeier Petra. Serratia marcescens: an outbreak experience. Front Microbiol. 2014;5(81):1\u20132.","journal-title":"Front Microbiol."},{"issue":"APR","key":"1267_CR33","first-page":"1","volume":"5","author":"GL Rosano","year":"2014","unstructured":"Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol. 2014;5(APR):1\u201317.","journal-title":"Front Microbiol."},{"issue":"2","key":"1267_CR34","first-page":"1","volume":"59","author":"NK Tripathi","year":"2013","unstructured":"Tripathi NK, Sathyaseelan K, Jana AM, Rao PVL. High yield production of heterologous protein in Escherichia coli. Def Sci J. 2013;59(2):1\u201310.","journal-title":"Def Sci J"},{"issue":"14","key":"1267_CR35","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1093\/nar\/14.14.5843","volume":"14","author":"K Nakahama","year":"1986","unstructured":"Nakahama K, Yoshimura K, Marumoto R, Kikuchi M, Lee IS, Hase T, Matsubara H. Cloning and sequencing of Serratia protease gene. Nucleic Acids Res. 1986;14(14):5843\u201355.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1267_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2672.2008.04042.x","volume":"106","author":"AN Li","year":"2009","unstructured":"Li AN, Li DC. Cloning, expression and characterization of the serine protease gene from Chaetomium thermophilum. J Appl Microbiol. 2009;106(2):369\u201380.","journal-title":"J Appl Microbiol"},{"issue":"1","key":"1267_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2091-12-17","volume":"12","author":"K Kwon","year":"2011","unstructured":"Kwon K, Hasseman J, Latham S, Grose C, Do Y, Fleischmann RD, et al. Recombinant expression and functional analysis of proteases from Streptococcus pneumoniae, Bacillus anthracis, and Yersinia pestis. BMC Biochem. 2011;12(1):17.","journal-title":"BMC Biochem."},{"issue":"2","key":"1267_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF01837059","volume":"13","author":"PS Aiyappa","year":"1976","unstructured":"Aiyappa PS, Harris JO. The extracellular metalloprotease of Serratia marcescens: I. Purification and characterization. Mol Cell Biochem. 1976;13(2):95\u2013100.","journal-title":"Mol Cell Biochem."},{"issue":"1","key":"1267_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2859-4-1","volume":"4","author":"HP S\u00f8rensen","year":"2005","unstructured":"S\u00f8rensen HP, Mortensen KK. Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact. 2005;4(1):1\u20138.","journal-title":"Microb Cell Fact."},{"issue":"1","key":"1267_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.pep.2004.04.025","volume":"37","author":"L Dumon-Seignovert","year":"2004","unstructured":"Dumon-Seignovert L, Cariot G, Vuillard L. The toxicity of recombinant proteins in Escherichia coli: a comparison of overexpression in BL21(DE3), C41(DE3), and C43(DE3). Protein Expr Purif. 2004;37(1):203\u20136.","journal-title":"Protein Expr Purif"},{"key":"1267_CR41","first-page":"1","volume":"SUPPL. 61","author":"DM Francis","year":"2010","unstructured":"Francis DM, Page R. Strategies to optimize protein expression in E. coli. Curr Protoc Protein Sci. 2010;SUPPL. 61:1\u201329.","journal-title":"Curr Protoc Protein Sci."},{"issue":"19","key":"1267_CR42","doi-asserted-by":"publisher","first-page":"16997","DOI":"10.1074\/jbc.M110.210393","volume":"286","author":"AC Sotomayor-P\u00e9rez","year":"2011","unstructured":"Sotomayor-P\u00e9rez AC, Ladant D, Chenal A. Calcium-induced folding of intrinsically disordered Repeat-in-Toxin (RTX) motifs via changes of protein charges and oligomerization states. J Biol Chem. 2011;286(19):16997\u20137004.","journal-title":"J Biol Chem"},{"issue":"5015","key":"1267_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1126\/science.1648264","volume":"253","author":"A Mitraki","year":"1991","unstructured":"Mitraki A, Fane B, Haase-petjingell C, Sturtevant J, King J. Global suppression of protein folding defects and inclusion body formation. Science. 1991;253(5015):54\u20138.","journal-title":"Science"},{"issue":"1","key":"1267_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-015-0222-8","volume":"14","author":"A Singh","year":"2015","unstructured":"Singh A, Upadhyay V, Upadhyay AK, Singh SM, Panda AK. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process. Microb Cell Fact. 2015;14(1):1\u201310.","journal-title":"Microb Cell Fact"},{"issue":"7","key":"1267_CR45","first-page":"1","volume":"6","author":"Z Yang","year":"2011","unstructured":"Yang Z, Zhang L, Zhang Y, Zhang T, Feng Y, Lu X, et al. Highly efficient production of soluble proteins from insoluble inclusion bodies by a two-step-denaturing and refolding method. PLoS ONE. 2011;6(7):1\u20138.","journal-title":"PLoS ONE"},{"issue":"6","key":"1267_CR46","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/nprot.2006.468","volume":"1","author":"A Shevchenko","year":"2007","unstructured":"Shevchenko A, Tomas H, Havli\u0161 J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2007;1(6):2856\u201360.","journal-title":"Nat Protoc"},{"key":"1267_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1385\/0-89603-268-X:9","volume-title":"Basic protein and peptide protocols","author":"NJ Kruger","year":"1994","unstructured":"Kruger NJ. The Bradford method for protein quantitation. In: Walker JM, editor. Basic protein and peptide protocols. Totowa: Humana Press; 1994. p. 9\u201315."},{"issue":"6","key":"1267_CR48","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/02681219480000581","volume":"32","author":"U Reichard","year":"1994","unstructured":"Reichard U, Eiffert H, R\u00fcchel R. Purification and characterization of an extracellular aspartic proteinase from Aspergillus fumigatus. Med Mycol. 1994;32(6):427\u201336.","journal-title":"Med Mycol"}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-019-1267-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12934-019-1267-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-019-1267-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:21:05Z","timestamp":1608078065000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbialcellfactories.biomedcentral.com\/articles\/10.1186\/s12934-019-1267-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1267"],"URL":"https:\/\/doi.org\/10.1186\/s12934-019-1267-x","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"9 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"An Indian patent application (201811029173) has been filed for the technology\/invention disclosed in the present work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"215"}}